Analysts expect Capricor Therapeutics, Inc. to report revenue of 43.91 M for Q3 26, against a range of 40.46 M to 47.36 M. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 2.26 M | 11.13 M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 4.36 M | 11.57 M | 3.36 M | 1.59 M | 652,497.45 | 594,682.57 | 0.00 | 0.00 | 47.36 M | 57.26 M | 6.89 M | 10.49 M | 46.44 M | 59.25 M | 54.61 M | 68.06 M | ||||||||||
| Low Estimate | 3.63 M | 10.78 M | 3.13 M | 1.44 M | 611,918.55 | 505,717.43 | 0.00 | 0.00 | 40.46 M | 50.22 M | 6.19 M | 9.61 M | 38.97 M | 52.88 M | 50.78 M | 56.72 M | ||||||||||
| Consensus Estimate | 3.99 M | 11.17 M | 3.24 M | 1.51 M | 632,208.00 | 550,200.00 | 0.00 | 0.00 | 43.91 M | 53.74 M | 6.54 M | 10.05 M | 42.71 M | 56.07 M | 52.70 M | 62.39 M |
Analysts expect Capricor Therapeutics, Inc. to report earnings per share of -0.14 for Q3 26, against a range of -0.15 to -0.13. The most recent reported quarter, Q2 26, came in at -0.70, a 22.8% miss against the -0.57 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.38 | -0.16 | -0.53 | -0.57 | -0.54 | -0.62 | -0.59 | -0.70 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.33 | -0.15 | -0.30 | -0.43 | -0.54 | -0.46 | -0.53 | -0.52 | -0.13 | -0.52 | -0.51 | -0.39 | -0.10 | -0.41 | -0.18 | -0.06 | ||||||||||
| Low Estimate | -0.35 | -0.17 | -0.32 | -0.49 | -0.64 | -0.52 | -0.57 | -0.62 | -0.15 | -0.56 | -0.59 | -0.43 | -0.10 | -0.47 | -0.20 | -0.06 | ||||||||||
| Consensus Estimate | -0.34 | -0.16 | -0.31 | -0.46 | -0.59 | -0.49 | -0.55 | -0.57 | -0.14 | -0.54 | -0.55 | -0.41 | -0.10 | -0.44 | -0.19 | -0.06 |
Pull Wall Street consensus for Capricor Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CAPR&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CAPR", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CAPR&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();